Literature DB >> 22807505

Comparison of serum treatments to remove nonspecific inhibitors from chicken sera for the hemagglutination inhibition test with inactivated H5N1 and H9N2 avian Influenza A virus subtypes.

Hye-Ryoung Kim1, Kyoung-Ki Lee, Yong-Kuk Kwon, Min-Su Kang, Oun-Kyung Moon, Choi-Kyu Park.   

Abstract

The hemagglutination inhibition (HI) assay is the standard diagnostic test for detection of antibodies to avian influenza viruses. It is well known that chicken serum does not require additional serum pretreatment to remove nonspecific inhibitors (NSIs). However, NSIs were recognized in certain Korean local breeds. In the present study, various treatments were compared to remove such NSIs. Heat treatment, red blood cell adsorption, and kaolin treatment did not remove NSIs effectively, and treatment with periodate only partly eliminated the NSIs. Receptor destroying enzyme (RDE) treatment appeared to effectively remove NSIs from chicken sera, regardless of breeds. It is proposed that RDE treatment should be included in the HI tests for serological diagnosis of avian Influenza A virus.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22807505     DOI: 10.1177/1040638712452732

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  3 in total

1.  Serologic investigation of exposure to influenza A virus H3N2 infection in dogs and cats in the United States.

Authors:  Sarah N Gutman; Lynn F Guptill; George E Moore; Roman M Pogranichniy
Journal:  J Vet Diagn Invest       Date:  2019-01-14       Impact factor: 1.279

2.  Mesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in mice.

Authors:  Yan Li; Jun Xu; Weiqing Shi; Cheng Chen; Yan Shao; Limei Zhu; Wei Lu; XiaoDong Han
Journal:  Stem Cell Res Ther       Date:  2016-10-28       Impact factor: 6.832

3.  Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in Eggs.

Authors:  Alfred T Harding; Brook E Heaton; Rebekah E Dumm; Nicholas S Heaton
Journal:  mBio       Date:  2017-06-06       Impact factor: 7.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.